Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomohiro Enokida

Showing results (1-10 of 63) with videos related to

Pageof 7
Sort By:
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[A Therapeutic Strategy Targeting Virus-Antigen in Cancer Treatment]Tomohiro Enokida
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Regulatory T cells: A target in anticancer immunotherapyTomohiro Enokida, Hiroyoshi Nishikawa
Cancers|April 3, 2021
Electrochemotherapy in the Treatment of Head and Neck Cancer: Current Conditions and Future DirectionsTomohiro Enokida, Makoto Tahara
Immunotherapy|June 28, 2017
Regulatory T cells, as a target in anticancer immunotherapyTomohiro Enokida, Hiroyoshi Nishikawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 16, 2012
[Treatment of patients with cancer of an unknown primary site]Tomohiro Enokida, Yu Ohyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 28, 2018
[I. Genomic Medicine in Thyroid Cancer]Tomohiro Enokida, Makoto Tahara
Cancers|November 13, 2021
Management of VEGFR-Targeted TKI for Thyroid CancerTomohiro Enokida, Makoto Tahara
The Journal of Clinical Investigation|May 3, 2021
Vaccines for immunoprevention of cancerTomohiro Enokida, Alvaro Moreira, Nina Bhardwaj
STAR Protocols|August 30, 2021
A T-cell-based immunogenicity protocol for evaluating human antigen-specific responsesCansu Cimen Bozkus, Ana Belen Blazquez, Tomohiro Enokida, et al.
Frontiers in Oncology|September 14, 2018
Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and NeckTomohiro Enokida, Susumu Okano, Takao Fujisawa, et al.
Pageof 7

Showing results (1-10 of 63) with videos related to

Sort By:
Pageof 7
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 13, 2025
[A Therapeutic Strategy Targeting Virus-Antigen in Cancer Treatment]Tomohiro Enokida
Nihon Rinsho. Japanese Journal of Clinical Medicine|December 19, 2018
Regulatory T cells: A target in anticancer immunotherapyTomohiro Enokida, Hiroyoshi Nishikawa
Cancers|April 3, 2021
Electrochemotherapy in the Treatment of Head and Neck Cancer: Current Conditions and Future DirectionsTomohiro Enokida, Makoto Tahara
Immunotherapy|June 28, 2017
Regulatory T cells, as a target in anticancer immunotherapyTomohiro Enokida, Hiroyoshi Nishikawa
Gan to Kagaku Ryoho. Cancer & Chemotherapy|May 16, 2012
[Treatment of patients with cancer of an unknown primary site]Tomohiro Enokida, Yu Ohyama
Gan to Kagaku Ryoho. Cancer & Chemotherapy|December 28, 2018
[I. Genomic Medicine in Thyroid Cancer]Tomohiro Enokida, Makoto Tahara
Cancers|November 13, 2021
Management of VEGFR-Targeted TKI for Thyroid CancerTomohiro Enokida, Makoto Tahara
The Journal of Clinical Investigation|May 3, 2021
Vaccines for immunoprevention of cancerTomohiro Enokida, Alvaro Moreira, Nina Bhardwaj
STAR Protocols|August 30, 2021
A T-cell-based immunogenicity protocol for evaluating human antigen-specific responsesCansu Cimen Bozkus, Ana Belen Blazquez, Tomohiro Enokida, et al.
Frontiers in Oncology|September 14, 2018
Paclitaxel Plus Cetuximab as 1st Line Chemotherapy in Platinum-Based Chemoradiotherapy-Refractory Patients With Squamous Cell Carcinoma of the Head and NeckTomohiro Enokida, Susumu Okano, Takao Fujisawa, et al.
Pageof 7